13
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous

Antitumour 1,5-diazaanthraquinones

Pages 977-980 | Published online: 25 Feb 2005

Bibliography

  • KRAPCHO AP, MARESCH MJ, HACKER MP et al.: Anthracene,-9,10-diones and aza bioisosteres as antitumor agents. Carr. Med. Chem. (1995) 2:803–824.
  • ••A review of nitrogen atom substitution on the anthracene-dione ring system and the antitumour properties of the resulting 'aza' derivatives.
  • BORCHMANN P, KNIPPERTZ R, SCHNELL R et al.: Pharma- cokinetics, and clinical results of the new aza- anthra-cenedione Bbr2778 in patients with advanced nonhodgkin, lymphomas. Blood (1999) 94:4364
  • •A poster describing recent clinical and pharmacokinetic findings of BbR2778.
  • FAIVRE S, BORCHMANN P, JODRELL D et al.: Bbr2778 a new, anthracenedione analogue with no preclinical cardiac toxicity: results from 3 phase I studies. Clin. Cancer Res. (1999) 5:329
  • •A poster describing recent clinical and pharmacokinetic findings of BbR2778.
  • DEISABELLA P, PALUMBO M, SISSI C et al.: Physico- chemical, properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenediones. Biochem. Pharmacol. (1997) 53:161–169.
  • WANG HK, MORRISNATSCHKE SL, LEE KH: Recent advances, in the discovery and development of topoisomerase inhibitors as antitumor agents. Med. Res. Rev. (1997) 17:367–425.
  • ••A recent review of topoisomerase II inhibitors as antitumouragents.
  • POMMIER Y: DNA topoisomerase II inhibitors. In: Cancer, Therapeutics. Teicher BA (Ed.), Humana Press Inc., Totowa, (1997) :153–174.
  • ••A recent review of topoisomerase II inhibitors as antitumouragents.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.